This study exists to explore whether a medication treatment could improve care and understanding. Researchers are trying to understand what a medication treatment could change in day-to-day care and decision-making.
In United States
Why is this study shown?
This study is directly about Bipolarity.
BipolarityDrugA study involving a medication or substance.From 10 Years to 17 Years
Countries
United States
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
This study exists to understand how this type of care holds up over time after the earliest research stage. Researchers are trying to understand how people respond to this type of care in practice and what may need to be adjusted.
In United States
Why is this study shown?
This study is directly about Bipolarity.
BipolarityDrugFrom 10 Years to 17 Years
Countries
United States
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
This study exists to explore whether blood tests and biological markers could improve care and understanding. Researchers are trying to understand whether blood tests and biological markers can improve attention, thinking, or day-to-day functioning.
This study exists to compare options and see whether the medication Olanzapine offers something meaningfully different. Researchers are trying to understand whether the medication Olanzapine can improve attention, thinking, or day-to-day functioning.
This study exists to understand whether the medication Aripiprazole is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to the medication Aripiprazole in practice and what may need to be adjusted.
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.
